BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Drug Development

  CILcare’s Age-Related Hearing Loss Model Enriched With NAC as Positive Control

  The antioxidant, NAC, delays the senescence process by slowing the age-related hearing loss and protecting cochlear hair cells of SAMP8 mice.

  February 8, 2018

   · 

  3 min read
• Drug Development

  Sanofi Announces New Safety Data for Investigational Avalglucosidase Alfa in Patients With Pompe Disease

  The study results were presented today at the 14th Annual WORLDSymposium 2018 in San Diego, California.

  February 8, 2018

   · 

  4 min read
• Business

  ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial Guidance

  Total revenue of $20.8 million, down 4% year-over-year on a reported basis and 5% on a constant currency basis.

  February 8, 2018

   · 

  12 min read
• Business

  City of Hope Appoints Jennifer Parkhurst as Chief Financial Officer and Mark Hulse as Chief Digital Officer

  Both are members of City of Hope’s Enterprise Leadership Team and report directly to the institution’s President and Chief Executive Officer Robert W. Stone.

  February 8, 2018

   · 

  3 min read
• joimax Continues Strong Growth Trend in 2017 with Launch of Its MultiZYTE Facet and SI Joint Treatment Set in the U.S.

  The joimax announces very strong sales figures for 2017.

  February 8, 2018

   · 

  3 min read
• Resverlogix Highlights Key Accomplishments and 2018 Targets

  The Company has recently achieved several major accomplishments:

  February 8, 2018

   · 

  5 min read
• Business

  Cambrex Reports Fourth Quarter and Full Year 2017 Financial Results

  Net revenue increased 2.5% to $182.3 million compared to $177.9 million in the same quarter last year.

  February 8, 2018

   · 

  17 min read
• 

  Business

  Immunocore CEO Steps Down, Effective Immediately

  Dr Forster informed the Board of his decision earlier this week and will be replaced, in an interim capacity, by Chief Commercial Officer Andrew Hotchkiss.

  February 8, 2018

   · 

  3 min read
• Drug Development

  pSivida’s Second Phase III Study for Durasert Three-Year Treatment for Posterior Segment Uveitis Maintains Positive Efficacy and Safety Profile at 12 Months

  The study involved 153 patients with posterior segment uveitis.

  February 8, 2018

   · 

  7 min read
• Business

  OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results

  Consolidated net revenues for the fourth quarter of 2017 were $52.0 million, a 47% increase from the fourth quarter of 2016.

  February 8, 2018

   · 

  17 min read